PROCEPT BioRobotics (PRCT) Enterprise Value (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Enterprise Value data on file, last reported at -$245.6 million in Q1 2026.

• On a quarterly basis, Enterprise Value rose 22.32% year-over-year to -$245.6 million in Q1 2026; TTM through Mar 2026 was -$245.6 million, a 22.32% increase from a year earlier, with the FY2025 full-year figure at -$275.1 million, up 17.57% from the prior year.
• Enterprise Value for Q1 2026 stood at -$245.6 million, up from -$275.1 million in the prior quarter.
• Over the last five years, Enterprise Value for PRCT reached as high as -$150.5 million in Q2 2023 and fell as low as -$333.7 million in Q4 2024.
• Historically, Enterprise Value has averaged -$253.4 million across 5 years, with a median of -$257.2 million in 2023.
• Across the five-year window, Enterprise Value plunged 230.11% in 2022 and surged 44.23% in 2023, its largest moves.
• Year by year, Enterprise Value stood at -$222.6 million in 2022, then fell by 15.53% to -$257.2 million in 2023, then declined by 29.74% to -$333.7 million in 2024, then advanced by 17.57% to -$275.1 million in 2025, then increased by 10.7% to -$245.6 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$245.6 million in Q1 2026, -$275.1 million in Q4 2025, and -$294.3 million in Q3 2025.